![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
Real-World Clinical Data of Palbociclib in Asian Metastatic Breast Cancer Patients: Experiences from Eight Institutions |
Jieun Lee, Hyung Soon Park, Hye Sung Won, Ji Hyun Yang, Hee Yeon Lee, In Sook Woo, Kabsoo Shin, Ji Hyung Hong, Young Joon Yang, Sang Hoon Chun, Jae Ho Byun |
Cancer Research and Treatment. 2021;53(2):409-423. Published online 2020 October 28 DOI: https://doi.org/10.4143/crt.2020.451 |
Real-World Clinical Data of Palbociclib in Asian Metastatic Breast Cancer Patients: Experiences from Eight Institutions REAL-WORLD SURVIVAL DATA OF PALBOCICLIB IN ADVANCED AND METASTATIC BREAST CANCER: A MULTICENTER EXPERIENCE IN LEBANON Treatment patterns and clinical outcomes in patients with metastatic breast cancer treated with palbociclib-based therapies: Real-world data in the Han population Treatment Patterns and Clinical Outcomes in Patients with Metastatic Breast Cancer Treated with Palbociclib-Based Therapies: Real-World Data in the Han Population PALBOCICLIB REAL WORLD DATA IN ADVANCED AND METASTATIC BREAST CANCER TREATED: A MULTICENTER EXPERIENCE IN LEBANON Real-World Effectiveness of Palbociclib Versus Clinical Trial Results in Patients With Advanced/Metastatic Breast Cancer That Progressed on Previous Endocrine Therapy Real-World Treatment Patterns and Outcomes of Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer: Flatiron Database Analysis Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy Real world treatment patterns and clinical outcomes of advanced/metastatic breast cancer patients receiving palbociclib in combination with an aromatase inhibitor: Results from the IRIS Study Real world data on use of palbociclib in hormone-receptor (ER) positive HER2 negative metastatic breast cancer (MBC) among Asian patients |
This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014. |